Talking About Men's Health™

The American Fertility Association (The AFA) and Men’s Health Network (MHN) have joined forces to disseminate monthly articles about Male Reproductive Health. As you’ll read in the introduction from Dr. Ajay Nangia and Dr. Stanton Honig, below, the articles are being generated from a collaborative organization called MRHA – the Male Reproductive Health Alliance, of which The AFA and MHN are founding members.

Continue Reading

Most men enjoy a beer, tumbler of whiskey, or glass of wine coming home from the grind, going out with friends and family, or just to take a load off. Many people can benefit socially, mentally, or even spiritually from moderate alcohol consumption. However, the physiological benefits of alcohol consumption have been debated amongst the ranks for decades. One only has to do a rudimentary literature search to view the rich history of the argument.

Continue Reading

by Dr. Perry Karfunkel

March 1, 2011

Comment

“Metabolic Syndrome” is a relatively new term that is used to describe people who are at elevated risk for heart disease. As in many things, the definition varies depending on who is doing the defining, but the outcome is agreed upon by all concerned. Metabolic Syndrome is present in 50% of all people with coronary artery atherosclerosis and it is present in up to 25% of Americans. Its presence increases a person’s risk for having a heart attack by 2.5 times, plain and simple. Continue Reading

The following essay is the first in a new series of authored pieces where Dr. Michael J. Rovito comments on and critiques new research focusing on topics related to men’s health. This commentary series is meant to help translate sometimes confusing, jargon-filled research into a format that is easily digestible by all readers concerned about their health and well being.

Continue Reading

Yesterday, the Medicare Evidence Development and Coverage Advisory Committee’s (MEDCAC) vote on a number of questions amounted to a recommendation to the Centers for Medicare and Medicaid Services (CMS) to cover Provenge, a therapeutic vaccine for men with advanced prostate cancer.  While the recommendation was not overwhelmingly enthusiastic, Provenge clears one hurdle on its way to Medicare coverage.  CMS is expected to make its final recommendation in the next few months.  This is a small victory for the estimated 100,000 men who have advanced prostate cancer and the process has not been without controversy. Continue Reading

That battle against prostate cancer is fought on many fronts:  Patients, their families and medical providers actively fight the disease, researchers toil to find the right combination of molecules or technology to find, treat and prevent the disease, and advocates raise awareness and labor to change public policy.  This multi-theater struggle is to end suffering from the most common form of cancer in men according to the CDC.

Continue Reading